Showing results (61-70 of 148) with videos related to
Sort By:
Pageof 15
Platelets|March 6, 2012
Inhibition of platelet aggregation by prostaglandin E1 (PGE1) in diabetic patients during therapy with clopidogrel and aspirinRolf P Kreutz, Perry Nystrom, Yvonne Kreutz, et al.Platelets|May 17, 2014
Platelet factor XIIIa release during platelet aggregation and plasma clot strength measured by thrombelastography in patients with coronary artery disease treated with clopidogrelRolf P Kreutz, Janelle Owens, Deshun Lu, et al.Hormones & Cancer|October 8, 2011
Functional characterization of a genetic polymorphism in the promoter of the ESR2 geneSantosh Philips, Alexandra Richter, Steffi Oesterreich, et al.The American Journal of Cardiology|February 22, 2005
Effect of cirrhosis and liver transplantation on the gender difference in QT intervalAdegboyega Q Adigun, Amar G Pinto, David A Flockhart, et al.Pharmacogenetics and Genomics|June 11, 2009
Identification of genetic variants in the human indoleamine 2,3-dioxygenase (IDO1) gene, which have altered enzyme activityMillion Arefayene, Santosh Philips, Donghua Cao, et al.Journal of Cardiovascular Pharmacology|September 3, 2011
Tamoxifen and its metabolites cause acute vasorelaxation of aortic rings by inducing vasodilator prostanoid synthesisMarcelo F Montenegro, Carla S Ceron, Maria C O Salgado, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2013
Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifenJinzhong Liu, Peter J Flockhart, Deshun Lu, et al.Bioorganic & Medicinal Chemistry|September 21, 2016
A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and βLi-Ming Zhao, Hai-Shan Jin, Jinzhong Liu, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 23, 2013
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stentingRolf P Kreutz, Janelle Owens, Jeffrey A Breall, et al.Drug Metabolism and Drug Interactions|September 12, 2002
Pharmacokinetics of fluvoxamine in relation to CYP2C19 phenotype and genotypeMichael W Jan, Troy L ZumBrunnen, Yusuf R Kazmi, et al.Pageof 15